loading

Bristol Myers Squibb Co Azioni (BMY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
12.92%
12,973.00
11,489.00 12,502.00 12,222.00 12,269.00
Cost Of Revenue
8.92%
3,726.00
3,421.00 4,097.00 3,435.00 3,372.00
Selling, General, and Administrative
12.93%
1,826.00
1,617.00 - - -
Costs And Expenses
7.72%
8,887.00
8,250.00 11,032.00 9,108.00 10,496.00
Income/Loss From Equity Method Investments
140.00%
60.00
25.00 100.00 -6.00 -37.00
Income/Loss From Continuing Operations Before Tax
26.11%
4,086.00
3,240.00 1,470.00 3,114.00 1,773.00
Income Tax Expense/Benefit, Deferred
221.12%
-195.00
161.00 -392.00 -359.00 -437.00
Income Tax Expense/Benefit
37.25%
770.00
561.00 384.00 919.00 460.00
Net Income/Loss
23.82%
3,316.00
2,678.00 1,085.00 2,195.00 1,313.00
Basic Average Shares
0.20%
2,042.00
2,038.00 - 2,036.00 2,035.00
Diluted Average Shares
0.05%
2,048.00
2,047.00 - 2,039.00 2,038.00
Basic Earnings Per Share
23.66%
1.62
1.31 0.54 1.08 0.64
Diluted Earnings Per Share
23.66%
1.62
1.31 0.53 1.08 0.64
Common Stock Dividends
0.00%
0.63
0.63 - 0.62 0.62
SNY SNY
$40.07
price down icon 0.40%
GSK GSK
$46.50
price down icon 0.09%
PFE PFE
$28.28
price up icon 1.65%
NVO NVO
$38.64
price up icon 1.20%
$151.17
price up icon 2.77%
$225.71
price up icon 3.33%
Capitalizzazione:     |  Volume (24 ore):